[144] Dolby Laboratories, Inc. SEC Filing
Dolby Laboratories (DLB) filed a Form 144 indicating a planned sale of restricted stock. The notice covers the proposed sale of 6,164 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $407,563.68. The filing notes that 60,845,846 shares of the issuer’s common stock are outstanding.
The shares to be sold were originally acquired as restricted stock from the issuer in multiple grants between 2013 and 2021, including blocks of 2,356 shares on 12/15/2020 and 1,627 shares on 12/16/2021, all listed as fully paid in cash or not requiring additional consideration. The person on whose behalf the sale is planned represents that they are not aware of any undisclosed material adverse information about the company’s operations.
- None.
- None.